Sucrose but not nitrate ingestion reduces strenuous cycling - Induced Intestinal Injury by Jonvik, Kristin L. et al.
Sucrose but Not Nitrate Ingestion Reduces
Strenuous Cycling–induced Intestinal Injury
KRISTINL. JONVIK1,2, KAATJE LENAERTS3, JOEY S. J. SMEETS1, JEROEN J. KOLKMAN4, LUC J. C. VAN LOON1,2,
and LEX B. VERDIJK1
1Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University
Medical Centre+, Maastricht, THE NETHERLANDS; 2Institute of Sports and Exercise Studies, HAN University of Applied
Sciences, Nijmegen, THE NETHERLANDS; 3Department of Surgery, NUTRIM School of Nutrition and Translational Research
in Metabolism, Maastricht University Medical Centre+, Maastricht, THE NETHERLANDS; and 4Medisch Spectrum Twente,
Enschede and University Medical Center, Groningen, THE NETHERLANDS
ABSTRACT
JONVIK, K. L., K. LENAERTS, J. S. J. SMEETS, J. J. KOLKMAN, L. J. C. VAN LOON, and L. B. VERDIJK. Sucrose but Not Nitrate
Ingestion Reduces Strenuous Cycling–induced Intestinal Injury. Med. Sci. Sports Exerc., Vol. 51, No. 3, pp. 436–444, 2019. Purpose:
Strenuous exercise induces intestinal injury, which is likely related to splanchnic hypoperfusion and may be associated with gastrointestinal
complaints commonly reported during certain exercise modalities. Increasing circulating nitric oxide (NO) levels or inducing postprandial
hyperemia may improve splanchnic perfusion, thereby attenuating intestinal injury during exercise. Therefore, we investigated the effects of
both dietary nitrate ingestion and sucrose ingestion on splanchnic perfusion and intestinal injury induced by prolonged strenuous cycling.
Methods: In a randomized crossover manner, 16 well-trained male athletes (age, 28 T 7 yr;Wmax, 5.0 T 0.3 WIkg
j1) cycled 60 min at 70%
Wmax after acute ingestion of sodium nitrate (NIT; 800 mg NO3), sucrose (SUC; 40 g), or a water placebo (PLA). Splanchnic perfusion was
assessed by determining the gap between gastric and arterial pCO2 (gapg-apCO2) using gastric air tonometry. Plasma intestinal fatty acid–
binding protein (I-FABP) concentrations, reflecting enterocyte damage, were assessed every 20 min during and up to 60 min of postexercise
recovery. Results: The exercise protocol resulted in splanchnic hypoperfusion, as gapg-apCO2 levels increased during exercise (P G 0.001),
with no differences between treatments (P = 0.47). Although plasma I-FABP concentrations increased during exercise and postexercise
recovery for all treatments (P G 0.0001), the increase was different between treatments (P G 0.0001). Post hoc comparisons showed an
attenuated increase in I-FABP in SUC versus PLA (P = 0.020). In accordance, I-FABP area under the curve (AUC0–120) was significantly
lower in SUC versus PLA (57,270 T 77,425 vs 114,907 T 91,527 pgImLj1 per 120 min, P = 0.002). No differences were observed between
NIT and PLA (P = 0.99). Conclusion: Sucrose but not nitrate ingestion lowers intestinal injury evoked during prolonged strenuous cycling.
These results suggest that sucrose ingestion, but not nitrate, prevents hypoperfusion-induced gastrointestinal damage during exercise and, as
such, may help to lower exercise-related gastrointestinal complaints.KeyWords:GASTROINTESTINAL DAMAGE, HYPOPERFUSION,
ATHLETES, CYCLING, CARBOHYDRATE
N
utritional strategies implemented around exercise
are aimed to support or promote optimal performance
and address various factors such as dehydration,
glycogen depletion, and gastrointestinal discomfort (1).
Gastrointestinal complaints are frequently reported in en-
durance athletes, with the highest prevalence and severity
reported in ultraendurance runners and triathletes (2).
During strenuous exercise, sympathetic nervous system
activity is massively increased and redistributes blood from
the splanchnic (gastrointestinal) organs to serve the working
muscle (3). The consequence of this exercise-induced
splanchnic vasoconstriction is splanchnic ischemia, which
can lead to mucosal injury, impaired nutrient uptake, and loss
of gastrointestinal barrier functions (4). Previous work has
demonstrated that splanchnic hypoperfusion, measured by
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gastric tonometry during strenuous cycling exercise, is asso-
ciated with small intestinal injury, shown as increased plasma
intestinal fatty acid–binding protein (I-FABP) concentrations
(5). Although a causal relationship has not yet been established,
exercise-induced intestinal injury is likely related to the
development of gastrointestinal complaints that can acutely
hamper exercise performance (2). Importantly though, even in
the absence of acute gastrointestinal symptoms, an exercise-
induced reduction in splanchnic blood flow and the devel-
opment of intestinal injury can induce detrimental effects
such as reduced nutrient uptake around exercise (6) or even
chronic health complications (2). Therefore, interventional
strategies to attenuate intestinal injury could likely benefit
exercise performance both directly, i.e., improved nutrient
availability to sustain strenuous exercise, and indirectly, i.e.,
improved muscle repair and nutrient repletion, thus enhanc-
ing subsequent exercise performance, as well as prevention of
potential health issues on the long term.
It has been suggested that splanchnic blood flow can be
manipulated by increasing the local availability of nitric
oxide (NO) (7). NO is an important vasodilator, regulating
microvascular tone, leukocyte adhesion, thrombocyte ag-
gregation, and microvascular permeability (8). Being a
short-lived gas, NO cannot readily be applied to the gut, but
several NO donors can be used to increase the bioavail-
ability of NO. One NO donor that has been studied is
L-citrulline, which is converted into L-arginine, and further
oxidized upon activation of endothelial NO synthase
(eNOS) to produce NO (9). Interestingly, van Wijck et al.
(10) showed that ingestion of L-citrulline before exercise
preserves splanchnic perfusion and attenuates intestinal
injury during prolonged strenuous cycling. In line with the
recent interest in nitrate as a potent NO donor, it has been
suggested that dietary nitrate can also modulate splanchnic
perfusion (4). Circulating nitrate is actively taken up by the
salivary glands and concentrated in the saliva, where it can
be reduced to nitrite by facultative anaerobic bacteria in the
oral cavity. Upon swallowing the saliva, nitrite enters the
circulation and can be further reduced to NO via various
pathways (11). In a study in rats, oral nitrate supplemen-
tation was shown to increase gastric mucosal blood flow
(12). The role of dietary nitrate for gastrointestinal function
during exercise in humans has never been investigated.
Therefore, our first aim was to assess the effects of dietary
nitrate ingestion on splanchnic perfusion and intestinal in-
jury during prolonged strenuous cycling.
It is generally accepted that oral meal ingestion (13), and
glucose ingestion in particular (14), increases splanchnic
blood flow, a phenomenon referred to as postprandial
splanchnic hyperemia. One possible explanation is the NO
and adenosine A1 receptor-mediated microvascular vasodi-
lation during intestinal glucose absorption. A study in rats
showed that NOS inhibition significantly blunts the glucose-
induced vasodilation of the premucosal arterioles (15). Fur-
thermore, carbohydrate ingestion before and every 20 min
during exercise was recently shown to attenuate the increase
in I-FABP levels after 2 h of running at moderate intensity in
the heat (16). We aimed to extend on these findings by in-
vestigating the effects of carbohydrate ingestion on intestinal
injury as well as splanchnic perfusion during and after ex-
ercise. To this end, we used a strenuous cycling protocol as
stationary ergometer cycling allows for the assessment of
splanchnic perfusion using gastric tonometry. Although cy-
cling exercise typically results in less gastrointestinal com-
plaints, splanchnic perfusion is clearly reduced, and the
relative increase in I-FABP has been reported in the same
range as for running (5,10,16).
We hypothesized that both nitrate and carbohydrate in-
gestion improve splanchnic perfusion and attenuate intesti-
nal injury evoked during prolonged strenuous cycling.
Therefore, 16 well-trained male athletes performed a 60-min
strenuous cycling protocol (70% Wmax) after ingestion of
sodium nitrate, sucrose, or placebo. During exercise and
upon 60 min postexercise recovery, splanchnic perfusion
was measured by gastric tonometry and intestinal injury was
measured by plasma I-FABP concentrations.
METHODS
Subject’s characteristics. Sixteen male cyclists (28 T
7 yr, body mass index = 23.0 T 2.2 kgImj2) were included in
the present study. Before the experiments, individual maxi-
mal workload capacity (Wmax) was assessed on a stationary
cycle ergometer (Lode Excalibur Sport, Groningen, The
Netherlands), by completing an incremental exercise test
starting with a 5-min warm-up at 150 W and increasing with
50 W every 2.5 min until volitional exhaustion; subjects
were excluded when Wmax was G4.5 WIkg
j1. All subjects
were well-trained (9.4 T 3.3 h of weekly endurance training)
and had an average Wmax of 5.0 T 0.3 WIkg
j1. Furthermore,
they had no abdominal complaints during daily activities,
had no history of gastrointestinal diseases/disorders or ab-
dominal surgery, did not take any medications or dietary
supplements (e.g., beetroot juice and probiotics) interfering
with test outcomes, and were nonsmokers. After being in-
formed about the purpose and potential risks of the study, all
subjects provided written informed consent. The experi-
mental protocol and procedures were approved by the
medical ethics committee of Maastricht University Medical
Centre+ and conducted in accordance with the Declaration
of Helsinki (2013).
Study design and nutritional interventions. In this
randomized controlled crossover study, all subjects performed
60 min of cycling exercise at 70% Wmax on three test days.
During these test days, subjects ingested 200 mL of a test
beverage before and during exercise. On a test day, the sub-
ject was provided sodium nitrate (NIT), sucrose (SUC), or
placebo (PLA) interventions. Splanchnic perfusion was
assessed by gastric tonometry, and intestinal injury was
assessed by the rise in plasma I-FABP concentrations. For
each subject, testing was performed on the same day, at the
same time, with 1–2 wk between test days.








Test beverages. Each subject ingested one ‘‘salty’’
beverage dissolved in 200 mL tap water 150 min before
cycling (t = j150). The beverage contained either sodium
nitrate in NIT (1.1 g NaNO3, Food grade, F.C.C. Brenntag,
the Netherlands) or an equal amount of NaCl in SUC and
PLA (ESCO Steen-Consumptiezout, the Netherlands), with
similar taste, smell, and appearance. The dose of 800 mg
nitrate (in 1.1 g NaNO3) was chosen based on previous
studies reporting substantial increases in plasma nitrate and
nitrite concentrations and physiological effects such as re-
duction in blood pressure and/or performance benefits
(17,18). Furthermore, subjects ingested one beverage of
200mL 15min before (t =j15) as well as 30 min into cycling
(t = 30). The beverages contained either 20 g sucrose in SUC
(granulated sugar; Sundale, Breda, the Netherlands) or tap
water in NIT and PLA. The test beverages were identical in
appearance and smell, but since no additives or sweeteners
were used, a difference in taste was unavoidable between
sucrose andwater placebo. However, the subject_s knowledge
of the intervention was unlikely to affect the main outcomes.
Physical activity and dietary standardization. Subjects
maintained normal activities of daily living and recorded their
activity pattern 48 h before a test day but refrained from stren-
uous physical activity for 24 h before each test day. To ensure
that the diet before test days did not differ between interventions,
a standard evening meal was provided before each test day and
the subjects reported their dietary intake for the 48 h leading into
test day 1. Before test days 2 and 3, they received a copy of their
food diary and were instructed to repeat the exact intake. Sub-
jects were not allowed to consume alcohol and caffeine 24 and
12 h before testing, respectively. On the evening before each test
day, the subjects ingested ranitidine (150 mg; Accord Healthcare
Limited, UK) to inhibit gastric acid production and secretion.
The latter is necessary to enable gastric tonometry measurements
because the presence of acid in the stomach during tonometry
can buffer carbon dioxide molecules, thereby interfering with the
outcome of the tonometry measurements (19). An additional
150 mg of ranitidine was consumed on the test days at 7:00 AM,
2–3 h before start of tonometry measurements. Furthermore, to
prevent any attenuation in the reduction of nitrate to nitrite in the
oral cavity by commensal bacteria (11), subjects were asked to
refrain from using any antibacterial mouthwash/toothpaste and
tongue scraping from 1 wk before the first test until the day after
the last test day.
Experiments and sampling. All subjects reported to
the laboratory at 8:00 AM by car or public transport in an
overnight fasted state. After seated rest for 5 min, a Teflon
catheter was inserted in a dorsal hand vein of the subject, and
the hand was placed in a hot box set at 60-C to enable col-
lection of arterialized blood for analysis of arterial pCO2 levels
(20). For practical reasons, no hotbox was used during exer-
cise, but blood oxygen saturation never dropped below 95%,
confirming sustained arterialized blood (21). To measure gas-
tric pCO2, an 8-French tonometrics catheter (MEDI-LINE s.a.,
Liege, Belgium) was introduced via the nose into the stomach
of the subject and fixed to the nasal flares. Gastric pCO2 was
measured at 10-min intervals before, during, and up to 60 min
postexercise using an automated capnograph (Tonocap TC-
200; Datex-Ohmeda Oy, Helsinki, Finland). Arterialized blood
samples were collected at baseline (t = j150), before exercise
(t = j50, t = j30 and t = j10) and every 20 min during and
postexercise in heparin syringes (safePICOTM aspirator; Ra-
diometer Benelux BV, Zoetemeer, Netherlands), for determi-
nation of arterial pCO2. By subtracting the gastric and arterial
pCO2 values, the gapg-apCO2 per 20 min time point was
calculated as a measure of splanchnic perfusion (10). To-
nometry data were obtained from 14 subjects because of
inability to introduce the nasogastric catheter into the
stomach of one of the subjects and measurement errors in
one other subject. At each time point, a second blood
sample was collected into lithium–heparin tubes and centrifuged
immediately at 1000g for 5 min, at T4-C. Aliquots of plasma
were stored at j80-C for the subsequent analysis of plasma
I-FABP, lipopolysaccharide binding protein (LBP), nitrate,
nitrite, and glucose concentrations.
After a 5-min warm-up at 50% of the individual_s
preassessed Wmax, subjects continued cycling at 70% Wmax
(262 T 33 W) for 60 min (t = 0–60). Subjects were free to
cycle according to their own comfortable pace, with a
minimum of 50 rpm. If the subject was unable to maintain
950 rpm, workload was decreased in steps of 25 W. Per-
formance per test day was estimated by calculating the av-
erage workload throughout the 60-min exercise. Subjects
consumed water ad libitum, with a maximum of 200 mL
every 20 min during exercise. Intake during the first test day
was replicated on the subsequent test days. Including the
interventional beverages, all subjects ingested 800–1400 mL
water throughout the test day. Because gastric pCO2 levels
drop directly after fluid or meal ingestion due to dilution
rather than an actual change in pCO2 (22), the gastric pCO2
value directly after ingestion of a beverage was substituted
for the previous gastric pCO2 value (e.g., t = 30 was used
instead of t = 40) when calculating the gapg-apCO2. Gastric
pCO2 is shown to stabilize within 15–20 min after fluid
ingestion (23), and the values used for analysis are all
extending this period after fluid ingestion.
Secondary measurements included heart rate during exercise
(Polar Electro Oy, Kempele, Finland), rate of perceived exertion
after completion of the exercise (24), and a multiple factor gastro-
intestinal symptoms questionnaire using a VAS scale. The 16-item
questionnaire is adapted from Jeukendrup et al. (25), and 950% on
the scale is defined as a severe symptom. We report data as a
percentage of possible maximum achievable score for all four
moments of registration (t = j30, t = 60, t = 120 and 1 d after).
Plasma analysis. To evaluate the extent of small in-
testinal injury during and postexercise, plasma concentra-
tions of intestinal I-FABP were determined. Plasma I-FABP
levels were measured by an in-house developed enzyme-
linked immunosorbent assay (26). The assay is specific for
the detection of the I-FABP isoform, with a lower limit of
detection of 12.5 pgImLj1. The intra- and interassay co-
efficients of variation are 4.1% and 6.2%, respectively. To










provide further insight into the nature of exercise-induced
intestinal injury, plasma LBP was determined as a marker of
endotoxin translocation in response to exercise using an in-
house developed ELISA with a lower limit of detection of
200 pgImLj1 (27). Plasma nitrate and nitrite concentrations
were analyzed using the chemiluminescence technique
(NOA; Sievers NOA 280i; Analytix, Durham, UK) as de-
scribed previously (17). Plasma glucose was analyzed using
Uni Kit III (Roche, Basel, Switzerland).
Statistical analysis. Power calculations were based on
previously reported percentage changes in I-FABP area under the
curve (AUC) after L-citrulline versus placebo supplementation
during high-intensity exercise (10). This resulted in an effect size
of 1.19. Taking into account a power of 95% and an alpha level of
0.025 (for preplanned post hoc comparisons for PLA vs NIT and
PLA vs SUC), a minimum of 14 subjects should be included.
Normality of all data was verified by the Kolmogorov–Smirnov
test. The primary outcome parameters were AUC0–120 for I-FABP
(pgImLj1I120 min) and AUC0–60 for gapg-apCO2 (kPaI60 min)
and were analyzed using repeated-measures ANOVA with
‘‘treatment’’ (NIT, SUC or PLA) as within-subjects factor. Con-
tinuous data for absolute I-FABP concentrations, gapg-apCO2,
plasma nitrate, plasma nitrite, and plasma glucose were ana-
lyzed using repeated-measures ANOVA, with ‘‘time’’ and
‘‘treatment’’ as within-subjects factors. Other secondary pa-
rameters were analyzed using repeated-measures ANOVA,
with ‘‘treatment’’ as within-subjects factor. Statistical signifi-
cance was set at P G 0.05, and any interaction or main effect
was subsequently analyzed using a Bonferroni-corrected
post hoc test for preplanned comparisons (i.e., SUC vs PLA
and NIT vs PLA). All data were analyzed using SPSS 22.0
(IBM Corp., Armonk, NY) and are presented as mean T SD.
RESULTS
Plasma nitrate/nitrite and glucose. There were no
baseline differences between treatments for plasma nitrate
(P = 0.144; Fig. 1A) or nitrite (P = 0.694; Fig. 1B) con-
centrations. A significant time–treatment interaction was ob-
served for both plasma nitrate and nitrite concentrations (both
P G 0.0001). Post hoc analysis showed significantly higher
plasma nitrate and nitrite concentrations after NIT versus
PLA throughout the test day (both P G 0.0001), with no
differences between SUC and PLA. After NIT, plasma ni-
trate and nitrite concentrations were increased at all time
points when compared with baseline (P G 0.0001). Subtle
changes in plasma nitrate and nitrite concentrations were
also observed within SUC and PLA (Figs. 1A and 1B).
For plasma glucose concentrations, there were no baseline
differences between treatments (P = 0.181; Fig. 1C). There
was a significant time effect (P G 0.0001) and a trend for a
time–treatment interaction (P = 0.088). Plasma glucose
concentrations increased compared with baseline at t = 20
and t = 40 (P G 0.01), tended to be increased at t = 60 (P =
0.063), and decreased at t = 120 (P G 0.01). Furthermore,
plasma glucose was higher in SUC versus PLA at t = j10
(P = 0.008) and tended to be higher in SUC versus PLA at
t = 60 (P = 0.076).
Splanchnic perfusion. For gapg-apCO2 levels, no dif-
ferences were observed at baseline, and no time–treatment
interaction (P = 0.47) or overall effect of treatment (P =
0.53) was observed. However, there was a significant time
effect (P G 0.001), with post hoc analyses showing that for
FIGURE 1—Mean T SD plasma concentrations of nitrate (A), nitrite
(B), and glucose (C) after oral bolus of sodium nitrate (NIT), sucrose
(SUC), or placebo (PLA) in healthy young men (n = 16). Data were
analyzed with repeated-measures ANOVA. Plasma nitrate (A): *Sig-
nificantly different from baseline (main effect for all treatments; all
P G 0.001). #Significantly different in the NIT vs PLA treatment (P G
0.0001). Plasma nitrite (B): *Significantly different from baseline at
P G 0.05, only in the SUC and PLA treatment, and **P G 0.0001 only in
the NIT treatment. #Significantly different in the NIT vs PLA treatment
(P G 0.0001). Plasma glucose (C): *Significantly different from baseline
(main effect for all treatments; all P G 0.01). #Significantly different in
the SUC vs PLA treatment (P G 0.01).








all treatments, gapg-apCO2 levels significantly increased com-
pared with baseline at all time points during cycling (P G 0.01),
returning to baseline levels after exercise cessation (Fig. 2A).
In accordance, AUC for gapg-apCO2 during exercise was
significantly higher than zero, with no differences between
treatments (P = 0.64; Fig. 2B). Likewise, peak values for
gapg-apCO2 (P = 0.87) were not different between treatments.
Intestinal injury. Baseline plasma I-FABP concentra-
tions (at t = j150, before the first supplement) were not
different between treatments (NIT, 1037 T 309; SUC, 1213 T
385; PLA, 1171 T 384 pgImLj1; P = 0.26) and remained
stable until the onset of exercise. A significant time–treatment
interaction was observed for the plasma I-FABP concen-
trations throughout the exercise and postexercise period
(P G 0.0001; Fig. 3A). Post hoc analysis showed that the
increase over time was significantly lower in SUC versus
PLA from t = 60 through t = 120 (all P G 0.05). By contrast,
no differences were observed between NIT and PLA. After
SUC, plasma I-FABP was increased from baseline at t = 20,
t = 40, t = 60, and t = 80, but not at t = 100 and t = 120. After
NIT and PLA, plasma I-FABP remained elevated above
baseline at all time points during and postexercise. In ac-
cordance, AUC for the I-FABP concentrations during and
postexercise was significantly different between treatments
(P G 0.0001), with post hoc analysis showing lower I-FABP
AUC after SUC versus PLA (57,270 T 77,425 vs 114,907 T
91,527 pgImLj1I120 min, P = 0.002; Fig. 3B), with no dif-
ferences between NIT (125,106 T 83,591 pgImLj1I120 min)
and PLA (P = 0.99). Also, when plasma I-FABP was
expressed as percentage change from baseline, a difference
was observed between treatments, with peak values for the
percentage increase in plasma I-FABP from baseline being
significantly lower in SUC (179% T 60%) versus PLA
(249% T 88%, P = 0.004), with no differences between NIT
and PLA (299% T 120%, P = 0.31). No correlations between
gapg-apCO2 and I-FABP levels were found.
At baseline, no differences were observed in LBP con-
centrations between treatments (12.6 T 3.7, 12.9 T 3.5, and
FIGURE 2—Mean T SD gapg-apCO2 levels at baseline, during, and
postexercise (A) and AUC of gapg-apCO2 levels during exercise (B)
after consumption of sodium nitrate (NIT), sucrose (SUC), or placebo
(PLA) in healthy young men (n = 14). The data over time (A) were
analyzed with repeated-measures ANOVA. *Significantly different
from baseline (main effect for all treatments; all P G 0.01). AUC data
(B) were analyzed with a one-way ANOVA; no differences were ob-
served between treatments.
FIGURE3—Mean T SDabsolute plasma I-FABPconcentrations preexercise,
during and postexercise (A) and AUC of absolute plasma I-FABP
change (B) after consumption of sodium nitrate (NIT), sucrose (SUC),
or placebo (PLA) in young healthy men (n = 16). The data over time (A)
were analyzed with repeated-measures ANOVA. *Significantly
different from baseline at P G 0.05, only in the SUC treatment, and
**P G 0.01 only in the NIT and PLA treatment. #Significantly dif-
ferent in the SUC vs PLA treatment (P G 0.01). AUC data (B) were
analyzed using one-way ANOVA. #Significantly different compared with
PLA (P G 0.01).










12.6 T 4.0 KgImLj1 in NIT, SUC, and PLA, respectively).
LBP concentrations were increased by ~9% after exercise
(P G 0.001), with no differences between treatments (13.5 T
3.6, 14.1 T 3.1, and 14.2 T 4.3 KgImLj1 in NIT, SUC, and
PLA, respectively, P = 0.69).
Gastrointestinal complaints and exercise
performance. There was a low degree of gastrointestinal
complaints at all time points, with a small but significant in-
crease immediately after exercise (t =j30: 2.9% T 2.6%, t = 60:
4.8% T 4.7%, t = 120: 2.7% T 3.5%, 1 d after: 2.6% T 3.5%, P =
0.002 for time effect), with no difference between interventions
(P = 0.57). At t = 60, two subjects reported severe gastrointes-
tinal complaints after NIT (one urge to vomit and one flatulence)
and three subjects after PLA (one flatulence, one dizziness, and
one nausea). One subject experienced gastrointestinal com-
plaints during cycling on all three test days, likely related to the
exercise intensity, but was able to complete the test protocol
each test day. Average cycling power output did not differ be-
tween treatments (NIT, 247 T 34 W; SUC, 250 T 35 W; PLA,
249 T 32 W; P = 0.22). A tendency was observed toward re-
duced rating of perceived exertion in the SUC treatment (NIT,
17.4 T 1.3; SUC, 16.5 T 1.9; PLA, 17.4 T 1.5; P = 0.082). The
highest 1-min heart rate during cycling did not differ between
treatments (NIT, 178 T 12 bpm; SUC, 178 T 13 bpm; PLA,
180 T 13 bpm; P = 0.28).
DISCUSSION
Cycling for 60 min at 70% Wmax resulted in splanchnic
hypoperfusion and intestinal injury in well-trained cyclists.
We observed no differences in splanchnic perfusion between
treatments, and dietary nitrate did not affect intestinal injury.
However, sucrose ingestion attenuated the increase in plasma
I-FABP levels, indicative of a substantial reduction in cycling-
induced intestinal injury.
Strenuous exercise has been associated with splanchnic
hypoperfusion and intestinal injury (5), which is likely to
hamper gastrointestinal function, exercise performance, and
postexercise recovery (6). In line with this, after placebo
ingestion, the prolonged strenuous cycling protocol of the
current study led to a clear ~2-kPa increase in gapg-apCO2
levels within the first 20 min of exercise. This reflects a
rapid development of profound splanchnic hypoperfusion,
where blood flow is reduced to less than 30%–40% of
baseline levels (28,29). Furthermore, a clear increase in
plasma I-FABP levels throughout the exercise until 60 min
postexercise was seen, reflecting the development of intes-
tinal injury at this intensity and duration of cycling. The
plasma I-FABP concentrations presented in the current
study appear somewhat higher when compared with previ-
ous studies (5,10,16). Although Snipe et al. (16) corrected
for plasma volume changes, in the current study as well as in
previous work, we did not perform such corrections (5,10).
During strenuous exercise, plasma volume can decline with
~10% (30,31), and because we expected changes of I-FABP
to be substantially larger (9200%), we chose not to correct
for plasma volume. However, as a consequence, and as a
limitation of the current study, plasma I-FABP levels during
exercise may have been slightly overestimated, and direct
comparisons between studies should be performed with
caution. Furthermore, in light of the relatively high I-FABP
values reported here, it is important to note that baseline
I-FABP concentrations tend to vary substantially between
individuals and even within individuals between subsequent
test days, and I-FABP values are highly variable between
different ELISA kits (32). Therefore, we also report I-FABP
values as a percentage change from baseline. The increase in
plasma I-FABP levels at the end of exercise after placebo
ingestion (~250%) is in the same range as previous studies
using the same exercise protocol (5,10), and after prolonged
running in the heat (16). It should be noted though that be-
cause our baseline values were much higher, the absolute
change (~1600 pgImLj1) also appears to be higher, which
obviously complicates any direct comparison between
studies. As opposed to the profound gastrointestinal com-
plaints of running in the heat (16), the current study reports
large increases in plasma I-FABP levels while the com-
plaints were negligible. Yet, even in the absence of such
complaints, an association between intestinal injury and
impaired nutrient uptake has been reported (26), and such
impaired nutrient uptake could theoretically negate postexercise
recovery. Thus, in an attempt to attenuate the exercise-
induced splanchnic hypoperfusion and marked enterocyte
damage, we studied the effect of dietary intervention strate-
gies in the form of dietary nitrate and carbohydrate (sucrose)
ingestion.
Dietary nitrate ingestion increased plasma nitrate and ni-
trite concentrations by ~12- and ~3-fold, respectively, in line
with a previous study from our group supplementing the
same dose of sodium nitrate in well-trained cyclists (33).
However, the effective uptake of dietary nitrate in the cir-
culation and its endogenous conversion into nitrite did not
result in an improvement in splanchnic perfusion or intesti-
nal injury when compared with the placebo treatment. This
contradicts previous results after supplementation of another
NO donor L-citrulline. Using the same cycling protocol as in
the current study, van Wijck et al. (10) reported that 10 g
L-citrulline preserved splanchnic perfusion and attenuated the
increase in I-FABP levels during exercise, although these
benefits were not maintained in the recovery period. The
proposed mechanism was increased arginine-induced intra-
cellular NO production leading to improved perfusion, as
demonstrated in a mice model (34) where L-citrulline sup-
plementation indeed reduced intestinal microcirculatory
dysfunction and increased intracellular NO production.
L-citrulline induces NO production through the L-citrulline–
L-arginine–NOS pathway, which is highly oxygen dependent.
By contrast, NO production through the nitrate–nitrite–NO
pathway is gradually activated as oxygen tension and pH
decrease (35). Indeed, because the oxygen-dependent NOS
pathway can still be stimulated under conditions of splanchnic








hypoperfusion (10), such conditions may be suboptimal for
the nitrate–nitrite–NO pathway to be stimulated. Perhaps a
total blockage of the splanchnic blood flow resulting in a
highly hypoxic state would have been necessary to see an
effect of nitrate. Furthermore, the suppression of gastric
acid secretion by ranitidine ingestion increases gastric pH to
allow for an accurate gastric pCO2 measurement (19). As a
potential side effect though, the increased gastric pH could
have attenuated the gastric reduction of nitrite to NO (35).
This may partly explain our findings of a lack of effect of
dietary nitrate ingestion on exercise-induced gastrointestinal
hypoperfusion and damage.
Splanchnic hypoperfusion during high-intensity exercise
is caused by increased activity of the sympathetic nervous
system to redistribute blood flow from the splanchnic organs
to the working muscle (3). This centrally acting mechanism
can be counteracted by providing macronutrients during
exercise to stimulate local vasodilation, which could be an
effective strategy to prevent intestinal injury (10). It is well
known that oral meal ingestion (13), and glucose in partic-
ular (14), can improve intestinal blood flow in nonexercise
conditions. It has been shown that glucose-induced vasodi-
lation of premucosal jejunal arterioles is mediated through
adenosine A1 receptors, and that NO at least partially me-
diates the adenosine A1 receptor-induced vasodilation (15).
Many athletes consume sports drinks containing multiple-
transportable carbohydrates during exercise because these
have been shown to enhance exogenous carbohydrate oxi-
dation rates, postpone fatigue, and improve endurance per-
formance (36,37). As such, we investigated the effect of
sucrose ingestion (i.e., providing both glucose and fructose)
on splanchnic blood flow and intestinal injury during
prolonged strenuous cycling. Plasma glucose levels were
elevated in the 10–30 min after sucrose ingestion compared
with placebo, indicating an effect of exogenous ingestion on
top of the endogenous glucose production during cycling
(Fig. 1C). In contrast to dietary nitrate, sucrose ingestion
strongly attenuated the increase in plasma I-FABP levels
throughout both the exercise and postexercise period when
compared with placebo (Fig. 3A), and I-FABP AUC during
and after cycling was decreased by more than half after su-
crose ingestion. Peak I-FABP concentrations were only in-
creased from baseline by ~185% after sucrose, compared
with ~250% after placebo. The attenuation of the exercise-
induced increase in plasma I-FABP levels has previously
been seen after glucose, and also whey protein ingestion
during 2 h of running at 60% V̇O2max (16). The authors
recommended using carbohydrates rather than protein dur-
ing exercise because carbohydrates can support endotoxin
clearance and reduce stress markers, whereas protein seems
to increase gastrointestinal complaints. We extend on these
findings by showing the effectiveness of carbohydrate in-
gestion during strenuous cycling (i.e., 70% Wmax theoreti-
cally representing ~80% V̇O2max) and by measuring an
attenuated rise in I-FABP concentrations throughout exercise
and in the postexercise period. Furthermore, we observed
splanchnic hypoperfusion, which likely caused the observed
exercise-induced intestinal injury, but no clinically relevant
response in terms of endotoxin translocation (on average ~9%
increase in plasma LBP).
Despite the attenuation of intestinal injury, sucrose in-
gestion did not preserve splanchnic perfusion during exer-
cise. In line with this, a previous study found that glucose
ingestion increased portal vein flow at rest but did not lead
to a significant attenuation of the exercise-induced reduction
in blood flow (38). However, the expected mechanism for
the attenuated intestinal injury after sucrose ingestion would
be an improved splanchnic perfusion, potentially through
the NO-mediated glucose-induced vasodilation (15). The
lack of change in gapg-apCO2 levels after the sucrose inter-
vention compared with placebo could be attributed to a local
stimulation of perfusion at the site of intestinal villi tips, and
that the measured gastric blood flow thereby remained un-
affected. Gastric pCO2 has been shown to correlate well
with jejunal pCO2 at rest (39) but is not a direct marker of
total intestinal blood flow. A correlation between gastric
pCO2 and plasma I-FABP levels has been reported using
the same cycling protocol as the current study (5). However,
the profound exercise-induced hypoperfusion might limit the
possibility for the tonometry method to detect perfusion
changes corresponding with the reduction in systemic I-FABP
appearance as seen for the sucrose intervention in the current
study. Moreover, it is recommended to use gastric tonometry
in a fasted state, and a rise in gastric pCO2 after feeding can
be caused by a buffer effect of meal-induced gastric acid
secretion (22). We aimed to suppress basal gastric acid
production by providing ranitidine. Yet, we cannot rule out
the possibility that gastric acid secretion evoked by sucrose
ingestion was not sufficiently inhibited by ranitidine (22),
which is a limitation of this study. As such, gastric pCO2
values might have been elevated after sucrose ingestion,
overshadowing a potential effect of sucrose on the attenua-
tion of the exercise-induced hypoperfusion, thus explaining
the absence of a reduction in gapg-apCO2 levels after sucrose
ingestion.
The current study aimed to investigate splanchnic perfu-
sion and intestinal injury during prolonged strenuous cy-
cling. Intestinal injury has been associated with intestinal
inflammation and permeability, bacterial translocation, and
impaired nutrient absorption (4), and exercise-induced
cytokinemia has been associated with gastrointestinal com-
plaints (40). However, no correlation (41–43) or even an
inverse correlation (36) has been shown between I-FABP
levels and gastrointestinal complaints during prolonged and/or
high-intensity running activities reporting a high degree of
gastrointestinal complaints. Importantly, the difficulties of
obtaining objective measures of gastrointestinal complaints
may to some extent explain the lack of association with
intestinal injury. Furthermore, a transient increase in sys-
temic I-FABP levels does not represent a direct marker
for gastrointestinal complaints but rather reflects acute
enterocyte damage being indicative of temporary loss of










intestinal integrity and absorptive capacity. Indeed, reduced
dietary protein digestion and absorption rates have been
shown during recovery from a resistance-type exercise
session when I-FABP levels were increased during exercise
(26). Although a direct causal relationship remains to be
established, these findings could support the relevance of
this marker for enterocyte damage, even under asymptom-
atic conditions. In addition to enterocyte damage, systemic
cytokine levels are known to increase as a consequence
of exercise (5,16). These inflammatory markers could be
derived from the working muscle (44) as well as other tis-
sues, including the intestine. To address specifically the role
of the intestine in the systemic responses, we determined
LBP concentrations as a marker of endotoxin translocation.
Although plasma LBP increased slightly (by ~9%) from
pre- to postexercise, the increase was not different between
the interventions, making it difficult to relate this marker to
the observed intestinal injury. Furthermore, such modest
increases in plasma protein levels should be interpreted with
caution as they could be due to, e.g., a lower plasma volume
as a consequence of exercise (45).
Previously, intestinal injury has been associated with splanch-
nic perfusion (5), and the extent of splanchnic hypoperfusion
is likely related to the development of gastrointestinal com-
plaints; however, this has never been established (3). This
relationship is difficult to investigate because of the low de-
gree of gastrointestinal complaints seen in cycling exercise
models that are used to measure splanchnic perfusion
(5,10,38), just like for the current study. To further assess the
relation between splanchnic perfusion, intestinal injury, and
gastrointestinal complaints, as well as the effect of carbohy-
drate ingestion on these aspects, future work should recruit
athletes that are prone to gastrointestinal symptoms. In addi-
tion, our findings should be confirmed in exercise conditions
triggering a high degree of gastrointestinal complaints, such
as prolonged strenuous running in extreme conditions, al-
though the tools to assess splanchnic perfusion under such
conditions remain to be established.
In line with previous work in this area (16), our findings
suggest that consuming carbohydrates frequently and con-
sistently during exercise may represent a feasible protective
strategy against exercise-induced gastrointestinal distur-
bance. This is the case for all levels of athletes, as even
highly trained athletes may only be highly trained in a spe-
cific exercise and do not necessarily have highly trained
guts. Two weeks of repetitive gut challenge has been shown
to improve gastrointestinal complaints and reduce carbo-
hydrate malabsorption during endurance running, which
may have performance implications (36,37). The current
study shows that ingesting small amounts of carbohydrates
(2  20 g) shortly before and during cycling is sufficient to
strongly attenuate exercise-induced intestinal injury. We
propose that athletes experiencing ischemia-related gastro-
intestinal complaints during exercise of high-intensity and/or
long duration could benefit from practicing carbohydrate
ingestion during exercise. For instance, ingesting 20 g of
carbohydrate from sport drinks or gels every 20 min of
prolonged endurance exercise, in line with the recommen-
dation of ~60 gIhj1 carbohydrate ingestion (1), can be an
optimal strategy for athletes to limit intestinal injury. Future
work should investigate whether the attenuated increase in
I-FABP levels due to ingestion of carbohydrates during ex-
ercise in asymptomatic athletes can also improve postexercise
nutrient uptake to enhance early recovery and subsequent
performance.
CONCLUSION
Sucrose but not nitrate ingestion lowers intestinal injury
evoked during prolonged strenuous cycling. These results
suggest that sucrose ingestion, but not nitrate, prevents
hypoperfusion-induced gastrointestinal damage during ex-
ercise and, as such, may help to lower exercise-related gas-
trointestinal complaints.
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